COR Therapeutics, Inc. to Report / Webcast First Quarter 2001 Financial Results Tuesday, April 17, 2001.

Health/Medical Writers

SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--April 10, 2001

COR Therapeutics, Inc. (Nasdaq: CORR) announced today that it will report its first quarter 2001 financial results on Tuesday, April 17, 2001 at 8:00 a.m Eastern Standard Time (EST).

Two hours later, at 10:00 a.m. EST, as part of the Company's efforts to ensure full disclosure to all parties, COR Therapeutics will webcast a conference call live via the Company's internet site. The call will be led by Vaughn M. Kailian, President and Chief Executive Officer.

To access the live call or the 5-day archive, please log onto http://www.corr.com. Alternatively, the webcast may be accessed by logging onto http://www.vcall.com/NASApp/VCall/EventPage?ID=72534 Please connect to either website at least 10 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the live webcast.

COR Therapeutics, Inc. is dedicated to the discovery, development, and commercialization of novel pharmaceutical products for the treatment and prevention of severe cardiovascular diseases. COR has complementary research and development programs that seek to address critical needs in severe cardiovascular care, including unstable angina, acute myocardial infarction, deep vein thrombosis, and restenosis.